AOD9604 2mg


AOD9604 is a peptide that has been studied for its potential therapeutic effects in the field of obesity and weight loss. It is a modified form of human growth hormone (HGH) consisting of a fragment of the HGH molecule. AOD9604 specifically corresponds to the 177-191 amino acid sequence of the HGH polypeptide. Studies have suggested that AOD9604 exhibits potential benefits in various areas, including heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. Animal studies have indicated that AOD9604 can stimulate lipolysis, which refers to the breakdown or destruction of fat, while also inhibiting lipogenesis, the process of fat cell formation.

22 in stock

**This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This classification permits the only use of research chemicals for in vitro testing and laboratory research. This website only provides product information for educational purposes. It is illegal to introduce any form of bodily material into either people or animals. Only professionals with the appropriate training and licences should handle this product. This product may not be misbranded, used improperly, or labelled as a medication, food, or cosmetic because it is not one of those things.


AOD9604 is a peptide that stands for “Anti-Obesity Drug 9604.” It is a modified form of a fragment of human growth hormone (HGH) called HGH fragment 176-191. AOD9604 was originally developed as a potential treatment for obesity and weight loss.
The peptide is derived from the C-terminal region of human growth hormone, which is known to be responsible for its fat-reducing effects. AOD9604 has been specifically designed to target adipose (fat) tissue and increase the breakdown of fat in the body. It is believed to work by stimulating lipolysis, the process by which stored fat is broken down into free fatty acids that can be used as an energy source.

One of the purported advantages of AOD9604 is that it selectively targets fat cells while sparing muscle and other tissues. This specificity is intended to minimize side effects associated with other weight loss treatments that may affect multiple body systems.


AOD9604 Research:

AOD9604 is a synthetic peptide derived from human growth hormone (HGH) that has gained attention for its potential role in fat metabolism and weight loss. It is specifically designed to mimic the effects of a natural fragment of HGH known as fragment 176-191.

Here are some key findings from the existing research on AOD9604:

  • Fat loss: AOD9604 has been suggested to promote fat metabolism and inhibit fat accumulation. Some studies in animal models and small human trials have shown promising results regarding its ability to reduce body fat, particularly abdominal fat.
  • Metabolic effects: AOD9604 has been reported to improve insulin sensitivity, which could potentially benefit individuals with metabolic disorders such as obesity and type 2 diabetes. It may also have a positive impact on lipid profiles, reducing LDL cholesterol levels and improving overall lipid metabolism. These effects could potentially have indirect benefits for cardiovascular health.
  • Safety and tolerability: AOD9604 has generally been well-tolerated in the studies conducted so far, with no significant adverse effects reported.


Certificate of Analysis (COA) and High Performance Liquid Chromatography (HPLC)

Certificate of Analysis | Aod 9604 Peptide CanadaHigh Performance Liquid Chromatography | Aod 9604 Peptide Canada

AOD9604 2mg
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more